DrugPatentWatch Database Preview
ZOHYDRO ER Drug Profile
When do Zohydro Er patents expire, and when can generic versions of Zohydro Er launch?
Zohydro Er is a drug marketed by Pernix Ireland Pain and is included in one NDA. There are fourteen patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in ZOHYDRO ER is hydrocodone bitartrate. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
Summary for ZOHYDRO ER
| US Patents: | 14 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 10 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ZOHYDRO ER |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZOHYDRO ER |
| DailyMed Link: | ZOHYDRO ER at DailyMed |
Pharmacology for ZOHYDRO ER
| Drug Class | Opioid Agonist |
| Mechanism of Action | Opioid Agonists |
Medical Subject Heading (MeSH) Categories for ZOHYDRO ER
US Patents and Regulatory Information for ZOHYDRO ER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pernix Ireland Pain | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-006 | Oct 25, 2013 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Pernix Ireland Pain | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-003 | Oct 25, 2013 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Pernix Ireland Pain | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-003 | Oct 25, 2013 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZOHYDRO ER
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg | ➤ Subscribe | ➤ Sign Up |
